Belite Bio (BLTE) Share-based Compensation (2022 - 2025)
Belite Bio (BLTE) posted quarterly Share-based Compensation of $11.7 million for Q4 2025, up 366.59% year-over-year from $2.5 million in Q4 2024, and up 366.59% quarter-over-quarter from -$4.4 million in Q4 2024.
Belite Bio (BLTE) Share-based Compensation (2022 - 2025) Analysis & Trends
Belite Bio's Share-based Compensation history runs 4 years deep, the most recent figure standing at $11.7 million for Q4 2025.
- In Q4 2025, Share-based Compensation rose 366.59% year-over-year to $11.7 million; the TTM figure through Dec 2023 stood at $3.4 million (up 571.79% YoY), while the FY2025 annual figure was $38.9 million, up 1377.56% from the prior year.
- Share-based Compensation for Q4 2025 stood at $11.7 million, up from -$4.4 million in the prior quarter.
- The five-year high for Share-based Compensation was $11.7 million in Q4 2025, with the low at -$4.4 million in Q4 2024.
- The 4-year median for Share-based Compensation is $2.0 million (2022), against an average of $2.8 million.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation surged 571.79% in 2023, then plunged 229.01% in 2024.
- Belite Bio's Share-based Compensation stood at $507000.0 in 2022, then soared by 571.79% to $3.4 million in 2023, then slumped by 229.01% to -$4.4 million in 2024, then soared by 366.59% to $11.7 million in 2025.
- Business Quant data shows BLTE's Share-based Compensation at $11.7 million in Q4 2025, -$4.4 million in Q4 2024, and $3.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.71 Mn |
| Dec 31, 2025 | 11.71 Mn |
| Dec 31, 2024 | -4.39 Mn |
| Dec 31, 2024 | -4.39 Mn |
| Dec 31, 2023 | 3.41 Mn |
| Dec 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 507,000.00 |
| Dec 31, 2022 | 507,000.00 |